New research suggests GLP-1 medications provide health benefits beyond weight loss, including reduced risk of heart attacks and strokes. Even patients who don't lose significant weight may still gain important cardiovascular protection from these drugs.
Posts published in “GLP-1”
Walmart has introduced new support services for people prescribed GLP-1 drugs for weight loss, focusing on nutrition and maintaining muscle mass. The program recognizes that the number on the scale is just one part of overall health and well-being during weight loss.
Changes in peptide regulations under RFK Jr.'s health policy could impact companies like Hims & Hers that offer GLP-1 medications online. The FDA review scheduled for 2026 will shape opportunities for these telehealth weight loss services.
Walmart is expanding its digital health platform to include weight management services and GLP-1 prescribing as the retail giant capitalizes on growing consumer interest in these weight-loss drugs. This move makes these medications more accessible through a major retail chain.
A new study found that people with a specific genetic variant may respond better to GLP-1 weight loss drugs like Ozempic and Wegovy. This discovery could help predict which patients will see the most success with these medications.
Doctors and patients are noticing that GLP-1 drugs like Ozempic may cause emotional changes, with some people feeling less excited or engaged with life. This "Ozempic personality" effect is being reported across social media and in medical practices.
Doctors and patients are reporting a concerning side effect called 'Ozempic personality' - emotional flattening that makes life feel bland while taking GLP-1 medications like Ozempic and Wegovy.
As demand for GLP-1 weight-loss drugs like Ozempic surges, many employers and insurance companies are struggling with the high costs. Some companies that want to offer these benefits to employees are being forced to drop coverage altogether due to expense.